Loading...
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
BACKGROUND: PAOLA1 is a phase III study assessing olaparib maintenance therapy in advanced high-grade ovarian carcinoma patients responding to first-line platinum-taxane–based chemotherapy plus bevacizumab as standard of care. Randomization was stratified by treatment outcome and tumor BRCA1/2 statu...
Saved in:
| Published in: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246800/ https://ncbi.nlm.nih.gov/pubmed/33372675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|